George Tachas

Company: Antisense Therapeutics

Job title: Director of Drug Discovery & Patents

Seminars:

Learning How Systemically Delivering Antisense Oligonucleotides Targeting CD49d RNA (ATL1102) Significantly Reduces New Active Brain Lesions in Patients With Relapse Remitting-Multiple Sclerosis 9:00 am

Analyzing Pharmacodynamics: Focus on circulating white blood cell observations Comprehensively analyzing safety data and pharmacokinetics Deep diving into the pharmacology of ASOs in the brainRead more

day: Day Two